Sterling Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.4K Buy
3,386
+2,397
+242% +$33.5K ﹤0.01% 1521
2025
Q1
$13.4K Sell
989
-784
-44% -$10.7K ﹤0.01% 1776
2024
Q4
$36.1K Buy
1,773
+1,516
+590% +$30.9K ﹤0.01% 1704
2024
Q3
$7.49K Buy
+257
New +$7.49K ﹤0.01% 1627